Acute Febrile Illness
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
BraccoItaly - Milan
1 programCauses and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast AsiaN/A1 trial
Active Trials
Allergy TherapeuticsUK - West Sussex
1 programThe Etiology of Acute Febrile Illness Requiring HospitalizationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BraccoCauses and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
Allergy TherapeuticsThe Etiology of Acute Febrile Illness Requiring Hospitalization
Clinical Trials (2)
Total enrollment: 1,492 patients across 2 trials
NCT04629053BraccoCauses and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
Start: Jun 2022Est. completion: Dec 2026
N/ARecruiting
The Etiology of Acute Febrile Illness Requiring Hospitalization
Start: Jul 2013Est. completion: Aug 20171,492 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,492 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.